PPG Industries, Inc. vs ResMed Inc. — how do they compare? PPG Industries, Inc. trades at $104.92 (market cap $23.44B), while ResMed Inc. trades at $230.57 (market cap $31.89B). The key difference: ResMed Inc. is the larger of the two by market cap, and PPG Industries, Inc. pays the higher dividend (2.81%). Which is the better fit depends on your goals — on Pluang, investors hold PPG Industries, Inc. for 68 Days and ResMed Inc. for 51 Days on average.
| PPG | RMD | |
|---|---|---|
Market Cap | $23.44B | $31.89B |
Volume | 2,064,777 | 618,314 |
Sector | Basic Materials | Health |
52-Week High | $131.56 | $277.88 |
52-Week Low | $94.34 | $182.82 |
Typical Hold Time | 68 Days | 51 Days |
Enterprise Value | $29.31B | $31.24B |
Dividend Yield | 2.81% | 1.16% |
Signals from Pluang's Aura AI — not financial advice
PPG Industries trades at $104.79, down 0.28% for the day, with a bearish technical signal from moving averages and neutral oscillators. The company reported 2025 revenue of $15.88 billion and net income of $1.58 billion, with a P/E ratio of 15.13. Recent earnings showed mixed results, missing in Q4 2025 and Q2 2026 but beating in Q1 2026. Analyst consensus is a Buy with a $130 price target, while recent news highlights margin pressures in the Automotive Refinish segment.
The outlook for PPG is cautiously optimistic, supported by strong profitability metrics like a 9.57% net income margin and 19.63% ROE, but risks include segment-specific weaknesses and macroeconomic headwinds. Upside potential exists if the company meets Q3 2026 earnings expectations and sustains cost-control measures, though investors should monitor auto refinish performance and global demand trends.
ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.
Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.
Trailing returns across standard periods
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →